C. Difficile

>

Latest News

Effectiveness of Oral Vancomycin in Preventing C diff Remains Uncertain after Trial
Effectiveness of Oral Vancomycin in Preventing C diff Remains Uncertain after Trial

July 7th 2025

The role of oral vancomycin in preventing recurrence of C difficile infection (CDI) in at-risk persons receiving systemic antibiotic for non-CDI infection remains unclear after randomized trial.

Top 5 Infectious Disease News Stories Week of June 28-July 5
Top 5 Infectious Disease News Stories Week of June 28-July 5

July 5th 2025

Real-World Use of Fecal Microbiota, live-jslm Shows High Success in Preventing Recurrent C difficile Infection
Real-World Use of Fecal Microbiota, live-jslm Shows High Success in Preventing Recurrent C difficile Infection

July 2nd 2025

AI Tool Demonstrates Potential to Support Antimicrobial Stewardship and Reduce C difficile in Hospitals
AI Tool Demonstrates Potential to Support Antimicrobial Stewardship and Reduce C difficile in Hospitals

June 30th 2025

Outpatient C difficile Cases Reveal Diagnostic Gaps and PPI-Linked Risks
Outpatient C difficile Cases Reveal Diagnostic Gaps and PPI-Linked Risks

June 20th 2025

© 2025 MJH Life Sciences

All rights reserved.